Besides transgelin-2, some targets (i.g., ESR1, EGFR, CASP3, and SRC) may be important for the anti-asthmatic effect of glycyrrhizin, and some signaling pathways (i.g., SRC/EGFR signaling pathway) are also promising research directions for improving asthma. The gene discussed is ESR1; the disease is asthma.